Related Experiment Video
Updated: Jun 6, 2026
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Initial management and follow-up of differentiated thyroid cancer in children
Steven G Waguespack1, Gary Francis
1Department of Endocrine Neoplasia & Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Insights
Differentiated thyroid cancer (DTC) in children requires specialized care due to high recurrence but low mortality. Management focuses on surgery, selective radioactive iodine (RAI) use, and lifelong thyroid hormone suppression.
Area of Science:
- Pediatric Oncology
- Endocrinology
- Surgical Oncology
Background:
- Differentiated thyroid cancer (DTC) in children frequently presents with metastatic disease.
- While DTC in pediatric patients has a low disease-specific mortality rate, the risk of recurrence is significant.
Purpose of the Study:
- To review current approaches for the initial care and long-term follow-up of pediatric DTC.
- To provide recommendations considering the unique risk profile of DTC in children.
Main Methods:
- Surgical management including total thyroidectomy and central compartment lymph node dissection by high-volume surgeons.
- Selective use of radioactive iodine (RAI) based on recurrence risk, residual disease, and metastatic status.
- Lifelong thyroid hormone suppression therapy and tailored disease surveillance.
Main Results:
- Total thyroidectomy and lymph node dissection are recommended for most pediatric DTC cases.
- RAI is indicated for very high-risk patients, those with residual disease, or iodine-avid metastases.
- RAI use requires careful risk-benefit assessment due to potential long-term adverse effects.
Conclusions:
- Pediatric DTC management necessitates a tailored approach balancing recurrence risk and treatment-related morbidity.
- Lifelong thyroid hormone suppression and vigilant, but de-escalating, surveillance are crucial for disease-free survivors.
Abstract:
Children with differentiated thyroid cancer (DTC) often present with metastatic disease and have a high risk for recurrence, but rarely die of the disease. This article reviews DTC in children and discusses current approaches to their initial care and follow-up. These recommendations take into account the greater risk for recurrence and lower disease-specific mortality in these patients. Total thyroidectomy and central compartment lymph node dissection are appropriate for most children, but should be performed by a high-volume thyroid surgeon. Radioactive iodine (RAI) should generally be prescribed for those at very high risk for recurrence or known to have microscopic residual disease, and those with iodine-avid distant metastases. RAI should be considered in other patients only after carefully weighing the relative risks and benefits and the aggressiveness of the clinical presentation, because RAI may be associated with an increased risk for second malignancies and an increase in overall morbidity and mortality. All patients should be treated with thyroid hormone suppression, and follow-up should be lifelong. However, the degree of thyroid hormone suppression and frequency of disease surveillance usually decrease over time as patients are determined to be disease-free.
